Kimba

Elevating Health and Sleep Through AI and Scent Technology

Startup

Kimba is a Tel Aviv-Yafo-based startup in the Health Tech & Life Sciences sector, established in 2024. Elevating Health and Sleep Through AI and Scent Technology. The company has raised a total of $1M across 1 funding round, currently at the Pre-Seed stage. Kimba was founded by Ben Fuxbruner and Gabi Beck. Key investors include techstars, Fresh Fund. The company has 1-10 employees. Core technologies: Artificial Intelligence.

With $1M in total funding, Kimba is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2G/B2B2C/B2B/B2C business model. Product stage: Clinical Trial.

$1M
Raised
1
Rounds
2
Investors
2
Team
2024
Founded
Sector & Technology
Health Tech & Life SciencesMedical DevicesArtificial Intelligence
At a Glance
Investors
Founders
Frequently Asked Questions
What does Kimba do?

Kimba is a developer of scent-based personal limbic therapy to analyze biometric data and offer a personalized scent therapy to improve sleep and health.

How much funding has Kimba raised?

Kimba has raised $1M in total funding across 1 rounds. The company is currently at the Pre-Seed stage. Key investors include techstars, Fresh Fund.

Who founded Kimba ?

Kimba was founded in 2024 by Ben Fuxbruner (Co-founder & CEO), Gabi Beck (Co-founder & CTO).

What sector is Kimba in?

Kimba operates in Health Tech & Life Sciences, Medical Devices, with core technologies in Artificial Intelligence. Target customers: Healthcare & Life Sciences, Healthcare, Patients, Consumers, Recreational & Lifestyle.

Where is Kimba located?

Kimba is based in Tel Aviv-Yafo, Israel, Center District. The company also has offices abroad.

View Full Profile Classic View Website ↗